EODData

MEMBERSHIP REGISTER LOG IN

ASX, CU6: Clarity Pharmaceuticals Ltd.

29 May 2026
LAST:

2.490

CHANGE:
 0.06		OPEN:
2.450		HIGH:
2.540		ASK:
3.420		VOLUME:
3.19M
CHG(%):
2.47		PREV:
2.430		LOW:
2.445		BID:
3.370		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
29 May 262.4502.5402.4452.4903.19M
28 May 262.5702.5902.4102.4302.58M
27 May 262.6802.7102.5802.6101.83M
26 May 262.6902.6902.5802.6602.14M
25 May 262.7502.7902.6402.7101.97M
22 May 262.7102.8302.7002.740999.8K
21 May 262.5302.7602.5302.7202.19M
20 May 262.6502.6602.4952.5202.27M
19 May 262.6302.6802.6002.6702.06M
18 May 262.9202.9652.5802.6003.85M

PROFILE

Name:Clarity Pharmaceuticals Ltd.
About:Clarity Pharmaceuticals Ltd, a clinical stage radiopharmaceutical company, engages in research and development of radiopharmaceuticals products for oncology in Australia and the United States. The company's lead product is SAR-bisPSMA, a theranostic radiopharmaceutical for the treatment of Prostate Specific Membrane Antigen (PSMA) cancer. It also develops SAR-Bombesin, a pan cancer theranostic radiopharmaceutical to treat prostate, breast, ovarian, urinary, small cell lung cancer, as well as glioblastoma and gastrointestinal stromal tumours; and SARTATE, a theranostic radiopharmaceutical for the treatment of somatostatin receptor 2 (SSTR2) cancer. The company was incorporated in 2010 and is based in Sydney, Australia.
Sector:Healthcare
Industry:Biotechnology
Address:National Innovation Centre, Sydney, NSW, Australia, 2015
Website:https://www.claritypharmaceuticals.com
ISIN:AU0000165375
FIGI:BBG011WVJ0K9

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

FUNDAMENTALS

Trailing P/E:-16.72 
Forward P/E:-9.93 
PEG Ratio:-14.51 
Price to Sales:132.10 
Price to Book:5.03 
Operating Margin:-8.23 
Return on Assets:-0.34 
Return on Equity:-0.54 
EPS Ratio:-0.28 
Revenue:9.46M 
Shares:372.26M 
Market Cap:926.92M 

TECHNICAL INDICATORS

MA5:2.583.6%
MA10:2.625.0%
MA20:2.7711.3%
MA50:2.9819.6%
MA100:3.1928.3%
MA200:3.5241.5%
STO9:15.00 
STO14:10.53 
RSI14:32.00 
WPR14:-87.23 
MTM14:-0.36
ROC14:-0.13 
ATR:0.16 
Week High:2.8313.7%
Week Low:2.413.3%
Month High:3.2329.7%
Month Low:2.4141.5%
Year High:5.87135.7%
Year Low:1.8435.3%
Volatility:4.89